Critical Survey: Titan Medical (NASDAQ:TMDIF) versus Daxor (NASDAQ:DXR)

Daxor (NASDAQ:DXR) and Titan Medical (NASDAQ:TMDIF) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their earnings, dividends, risk, valuation, profitability, analyst recommendations and institutional ownership.

Volatility and Risk

Daxor has a beta of -0.51, suggesting that its stock price is 151% less volatile than the S&P 500. Comparatively, Titan Medical has a beta of 1.26, suggesting that its stock price is 26% more volatile than the S&P 500.

Profitability

This table compares Daxor and Titan Medical’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Daxor	N/A	N/A	N/A
Titan Medical	N/A	-82.31%	-51.47%

Valuation & Earnings

This table compares Daxor and Titan Medical”s top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Daxor	N/A	N/A	N/A	N/A	N/A
Titan Medical	$17.63 million	3.06	$6.95 million	$0.05	9.47

Titan Medical has higher revenue and earnings than Daxor.

Analyst Recommendations

This is a summary of current ratings and target prices for Daxor and Titan Medical, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Daxor	0	0	1	0	3.00
Titan Medical	0	0	0	0	0.00

Daxor presently has a consensus target price of $24.75, indicating a potential upside of 201.09%. Given Daxor’s stronger consensus rating and higher probable upside, research analysts clearly believe Daxor is more favorable than Titan Medical.

Insider and Institutional Ownership

1.3% of Daxor shares are held by institutional investors. Comparatively, 0.0% of Titan Medical shares are held by institutional investors. 59.0% of Daxor shares are held by company insiders. Comparatively, 0.0% of Titan Medical shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Summary

Daxor beats Titan Medical on 7 of the 9 factors compared between the two stocks.

About Daxor

Daxor Corporation, a medical device company, provides blood volume measurement technology focused on blood volume testing. The company develops and markets BVA-100 Blood Volume Analyzer, a diagnostic blood test to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms for used in a broad range of medical and surgical conditions. The company was formerly known as Idant Corporation and changed its name to Daxor Corporation in May 1973. Daxor Corporation was incorporated in 1971 and is headquartered in Oak Ridge, Tennessee. Daxor Corporation is a subsidiary of Estate Of Joseph Feldschuh.

About Titan Medical

Titan Medical Inc. operates as a medical technology company. It focuses on the development and licensing of robotic assisted surgical technologies. The company is headquartered in Toronto, Canada.